147 related articles for article (PubMed ID: 9620628)
1. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
2. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
3. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
[TBL] [Abstract][Full Text] [Related]
4. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H
J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
6. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H
Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948
[TBL] [Abstract][Full Text] [Related]
7. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
8. Myocardial uptake of technetium-99m-furifosmin (Q12) versus technetium-99m-sestamibi (MIBI).
Bangard M; Bender H; Grünwald F; Hümmelgen M; Willkomm P; Palmedo H; Lüderitz B; Biersack HJ
Nuklearmedizin; 1999; 38(6):189-91. PubMed ID: 10510802
[TBL] [Abstract][Full Text] [Related]
9. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
de Jong M; Bernard BF; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; Krenning EP
Eur J Nucl Med; 1996 Oct; 23(10):1361-6. PubMed ID: 8781141
[TBL] [Abstract][Full Text] [Related]
10. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi.
Ding HJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Appl Radiat Isot; 2002 Jun; 56(6):853-6. PubMed ID: 12102342
[TBL] [Abstract][Full Text] [Related]
11. Effects of extracellular Na+ and Ca2+ ions and Ca2+ channel modulators on the cell-associated activity of 99mTc-MIBI and 99mTc-tetrofosmin in tumour cells.
Arbab AS; Ueki J; Koizumi K; Araki T
Nucl Med Commun; 2003 Feb; 24(2):155-66. PubMed ID: 12548040
[TBL] [Abstract][Full Text] [Related]
12. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
13. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J
Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium.
Matsunari I; Haas F; Nguyen NT; Reidel G; Wolf I; Senekowitsch-Schmidtke R; Stöcklin G; Schwaiger M
J Nucl Med; 2001 May; 42(5):818-23. PubMed ID: 11337582
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A
Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721
[TBL] [Abstract][Full Text] [Related]
16. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Al-Saeedi FJ; Bitar M; Pariyani S
J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
[TBL] [Abstract][Full Text] [Related]
17. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
[TBL] [Abstract][Full Text] [Related]
18. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
[TBL] [Abstract][Full Text] [Related]
19. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
[TBL] [Abstract][Full Text] [Related]
20. Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
Nucl Med Commun; 1997 Mar; 18(3):235-40. PubMed ID: 9106777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]